These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6594925)

  • 21. A phase II study of vindesine in patients with hematological malignancies.
    Hulhoven R; Michaux JL; Cornu G; Ferránt A; Bosly A; Delannoy A; Sokal G
    Biomedicine; 1980 Apr; 33(2):31-2. PubMed ID: 6931617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.
    Miller TP; Jones SE; Chester AB; Dorr RT
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():81-6. PubMed ID: 7438127
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of the blast crisis in chronic myeloid leukemia. Results of a phase II study with vindesine].
    Hellriegel KP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):699-706. PubMed ID: 6172337
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia.
    Chello PL; Sirotnak FM
    Cancer Treat Rep; 1981; 65(11-12):1049-53. PubMed ID: 7296551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate and asparaginase combination chemotherapy in refractory acute lymphoblastic leukemia of childhood.
    Lobel JS; O'Brien RT; McIntosh S; Aspnes GT; Capizzi RL
    Cancer; 1979 Mar; 43(3):1089-94. PubMed ID: 284840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II evaluation of vindesine in mycosis fungoides, extraosseous plasmacytoma and other hematologic malignancies.
    Ferrazzi E; Pappagallo GL; Segati R; Vinante O; Galligioni E; Zagonel V; Salvagno L; Fiorentino MV
    Tumori; 1982 Aug; 68(4):321-4. PubMed ID: 7147357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
    Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA
    J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.
    Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW
    J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II study of combined methotrexate and teniposide infusions prior to reinduction therapy in relapsed childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Ochs J; Rodman J; Abromowitch M; Kavanagh R; Harris M; Yalowich J; Rivera GK
    J Clin Oncol; 1991 Jan; 9(1):139-44. PubMed ID: 1985163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vindesine. A review of phase-II trials.
    Gralla RJ; Tan CT; Young CW
    Cancer Chemother Pharmacol; 1979; 2(4):271-4. PubMed ID: 455587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
    Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C
    J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vindesine in the treatment of leukaemia.
    Gökbuget N; Hoelzer D
    Leuk Lymphoma; 1997 Aug; 26(5-6):497-506. PubMed ID: 9389357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Acute lymphoblastic leukemia in childhood: the COALL studies].
    Janka GE; Winkler K; Jürgens H; Göbel U; Gutjahr P; Spaar HJ
    Klin Padiatr; 1986; 198(3):171-7. PubMed ID: 3523023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preliminary data on treatment with Vindesine in relapses of acute lymphoblastic leukemia].
    Jankovic M; Uderzo C; Rossi MR; Locasciulli A; Conter V; Masera G
    Haematologica; 1981 Oct; 66(5):710-2. PubMed ID: 6796480
    [No Abstract]   [Full Text] [Related]  

  • 35. Methotrexate-vindesine association in leukemia: pharmacokinetic study.
    Tubiana N; Lena N; Barbet J; Imbert AM; Lejeune C; Maraninchi D; Sainty D; Sebahoun G; Gastaut JA; Cano JP
    Med Oncol Tumor Pharmacother; 1985; 2(2):99-102. PubMed ID: 3864001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single high dose of idarubicin combined with high-dose ARA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University "La Sapienza" of Rome.
    Testi AM; Moleti ML; Giona F; Annino L; Chiaretti S; Del Giudice I; Todisco E; D'Elia G; Ferrari A; Arcese W; Mandelli F
    Haematologica; 1997; 82(6):664-7. PubMed ID: 9499665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction toxicity of a modified Memorial Sloan-Kettering-New York II Protocol in children with relapsed acute lymphoblastic leukemia: a single institution study.
    Morland BJ; Shaw PJ
    Med Pediatr Oncol; 1996 Sep; 27(3):139-44. PubMed ID: 8699989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group.
    Koizumi S; Fujimoto T; Takeda T; Yatabe M; Utsumi J; Mimaya J; Ninomiya T; Yanai M
    Cancer; 1988 Apr; 61(7):1292-300. PubMed ID: 3278798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas.
    Bayssas M; Gouveia J; Ribaud P; Musset M; de Vassal F; Pico JL; de Luca L; Misset JL; Machover D; Belpomme D; Schwarzenberg L; Jasmin C; Hayat M; Mathé G
    Cancer Chemother Pharmacol; 1979; 2(4):247-55. PubMed ID: 287569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vindesine in the treatment of refractory haematological malignant diseases.
    Young GA; Jurd J; Vincent PC
    Med J Aust; 1985 Feb; 142(3):189-90. PubMed ID: 3969034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.